Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Effects of Inspiratory Muscle Training and Neuromuscular Electrical Stimulation in Patients With Chronic Obstructive Pulmonary Disease
Verified date | May 2023 |
Source | Universidade Federal de Santa Maria |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic obstructive pulmonary disease (COPD) is a significant current public health problem, characterized by the presence of limited airflow. However, COPD has important manifestations beyond the lungs, the so-called systemic effects. These included dysfunction of peripheral and respiratory muscles. The growing amount of evidence has shown that patients with COPD also present important deficits in postural balance and consequently, increased risk of falling. As an essential part of the management of COPD, pulmonary rehabilitation (PR) alleviates dyspnea and fatigue, improves exercise tolerance and health-related quality of life, and reduces hospital admissions and mortality for COPD patients. Exercise is the key component of PR, which is composed of exercise assessment and training therapy. Currently, two modalities of therapy have been suggested as complementary to pulmonary rehabilitation: inspiratory muscular training (IMT) and neuromuscular electrical stimulation (NMES). Based on the premise that peripheral and respiratory muscle dysfunction can negatively impact postural control of patients with COPD, and given the importance of balance as a modifiable risk factor for falls, it is important to investigate whether the use of these therapeutic modalities (IMT and/or NMES) is capable of improving the short-term effects of pulmonary rehabilitation and also promoting improved balance.
Status | Completed |
Enrollment | 40 |
Est. completion date | March 10, 2023 |
Est. primary completion date | March 10, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 55 Years to 80 Years |
Eligibility | Inclusion Criteria: - Clinical diagnosis of COPD, in stages II, III and IV, according to criteria of the Global Initiative for COPD (GOLD); - Clinically stable, i.e., absence of infections or exacerbations in the last 3 months; - Medical team allows patient to exercise - Availability of attending the rehabilitation program. Exclusion Criteria: - Unstable primary pathologies (cardiovascular, renal, metabolic, psychiatric); - Hemodynamic instability; - Nutritional supplementation on the 4 weeks preceding the study; - Severe hearing or visual impairment recorded on patient chart or self-referred; - Obesity (BMI > 30 kg/m2); - Neurological or musculoskeletal condition that severely limits mobility and postural control, thus making it impossible to carry out the assessments; - Electronic devices, such as heart pacemakers and implantable cardioverter defibrillator; - Skin injuries and infection where electrodes would be placed; - Prior participation in pulmonary rehabilitation programs 3 months previous to the study; - Vertigo; - Active smoker and/or alcoholic; - Neurological impairment or cerebellar lesions; - Deficit in cognitive function; - Severe vitamin D deficiency; - Physically active. |
Country | Name | City | State |
---|---|---|---|
Brazil | Universidade Federal de Santa Maria | Santa Maria | Rio Grande Do Sul |
Lead Sponsor | Collaborator |
---|---|
Universidade Federal de Santa Maria |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Static postural balance | Static postural balance will be assessed on a portable force platform (AccuSway Plus, AMTI®, MA, USA) using the center of pressure displacement amplitude in the anteroposterior direction (COP) (cm). | Post-intervention (change after 8 weeks of training) | |
Primary | Static postural balance | Static postural balance will be assessed on a portable force platform (AccuSway Plus, AMTI®, MA, USA) using the area of ellipse (AE) (cm2). | Post-intervention (change after 8 weeks of training) | |
Primary | Static postural balance | Static postural balance will be assessed on a portable force platform (AccuSway Plus, AMTI®, MA, USA) using the velocity of displacement of center of pressure (COPvel) (cm/s). | Post-intervention (change after 8 weeks of training) | |
Primary | Static postural balance | Static postural balance will be assessed on a portable force platform (AccuSway Plus, AMTI®, MA, USA) using the center of area of pressure and area of ellipse (AE) (cm2). | Post-intervention (change after 8 weeks of training) | |
Secondary | Static postural balance | Static postural balance (%) will assessed through Foam-Laser dynamic posturography. | Post-intervention (change after 8 weeks of training) | |
Secondary | Static and dynamic postural balance | Static and dynamic postural balance will assessed using the Berg Balance Scale (score points). Scores range from 0 to 56, with higher scores indicating better balance. | Post-intervention (change after 8 weeks of training) | |
Secondary | Static and dynamic postural balance | Static and dynamic postural balance will assessed using the Balance Evaluation Systems Test (score points). The total score of the test (108 points) will be calculated with a percentage score (0-100%) and higher scores indicate better balance performance. | Post-intervention (change after 8 weeks of training) | |
Secondary | Dynamic postural balance | Dynamic postural balance will assessed using the Timed Up and Go (seconds). A faster time indicate a better functional performance and a score of =12 seconds used as a cut-point. | Post-intervention (change after 8 weeks of training) | |
Secondary | Balance confidence questionnaire | Balance confidence questionnaire will measured through the Activities Specific Balance Confidence Scale (total score points). The questionnaire contains 16 items scored on a range from 0% to 100% (0 indicating no confidence and 100 indicating full confidence). | Post-intervention (change after 8 weeks of training) | |
Secondary | Balance confidence questionnaire | Balance confidence questionnaire will measured through Falls Efficacy Scale-International (total score points). The total score ranges from 16 to 64 points. Higher values indicate less fall-related self-efficacy (and more concern about falling). | Post-intervention (change after 8 weeks of training) | |
Secondary | Peripheral muscle strength | Handgrip strength and quadriceps muscle strength will be assessed by dynamometry, respectively, Kgf and Newtons. | Post-intervention (change after 8 weeks of training) | |
Secondary | Respiratory muscle strength and inspiratory muscle endurance | Respiratory muscle strength (cmH2O) and inspiratory muscle endurance (cmH2O) will measured through digital pressure manometry and incremental and constant test, respectively | Post-intervention (change after 8 weeks of training) | |
Secondary | Quadriceps femoris and diaphragm thickness | Quadriceps femoris and diaphragm thickness will measured by ultrasonography | Post-intervention (change after 8 weeks of training) | |
Secondary | Submaximal level of functional capacity | Submaximal level of functional capacity will measured by 6-minute walk test | Post-intervention (change after 8 weeks of training) | |
Secondary | Health-related quality of life at 8 week | Health-related quality of life will measured by Saint George's Respiratory Questionnaire. Overall scores range from 0 (no effect on quality of life) to a maximum score of 100 (maximum perceived distress). | Post-intervention (change after 8 weeks of training) | |
Secondary | Oxidant profile | The oxidant profile will be assessed by Dichlorofluorescein Diacetate - DCF-DA (picomoles / mL). | Post-intervention (change after 8 weeks of training) | |
Secondary | Oxidant profile | The oxidant profile will be assessed by Thiobarbituric Acid Reactive Substances -TBARS (nmol de MDA/mL). | Post-intervention (change after 8 weeks of training) | |
Secondary | Oxidant profile | The oxidant profile will be assessed by Advanced Oxidation Protein Products - AOPPs (µmol/L). | Post-intervention (change after 8 weeks of training) | |
Secondary | Oxidant profile | The oxidant profile will be assessed by Total Oxidant Status - TOS (mmol Trolox Equiv/L). | Post-intervention (change after 8 weeks of training) | |
Secondary | Antioxidant profile | The antioxidant profile will be assessed by Ferric Reducing Antioxidant Power - FRAP- (µmol/L) | Post-intervention (change after 8 weeks of training) | |
Secondary | Antioxidant profile | The antioxidant profile will be assessed by Total Antioxidant Capacity- CAT (mmol Trolox Equiv/L). | Post-intervention (change after 8 weeks of training) | |
Secondary | Muscle damage | Muscle damage will assessed through creatine phosphokinase (total CPK) (U/L). | Post-intervention (change after 8 weeks of training) | |
Secondary | Muscle damage | Muscle damage will assessed through lactate dehydrogenase (LDH) (U/L). | Post-intervention (change after 8 weeks of training) | |
Secondary | Muscle damage | Muscle damage will assessed through lactate parameter (mg/dL). | Post-intervention (change after 8 weeks of training) | |
Secondary | DNA damage | DNA damage will assessed by means of the Comet and micronucleus assay | Post-intervention (change after 8 weeks of training) | |
Secondary | Endothelial function | Endothelial function will assessed through nitrite/nitrate oxide (NOx) (µmol/L) | Post-intervention (change after 8 weeks of training) | |
Secondary | Peripheral muscle resistance of the lower limbs | Peripheral muscle resistance of the lower limbs will assessed through 30-second Sit-to-Stand tests (repetitions) | Post-intervention (change after 8 weeks of training) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|